Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience

Title
Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience
Authors
Keywords
-
Journal
AIDS RESEARCH AND HUMAN RETROVIRUSES
Volume -, Issue -, Pages -
Publisher
Mary Ann Liebert Inc
Online
2023-09-30
DOI
10.1089/aid.2023.0070

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now